Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio

by Agoston Gyula Szabo, Tobias Wirenfeldt Klausen, Niels Abildgaard, Henrik Gregersen, Trine Silkjær, Per Trøllund Pedersen, Robert Schou Pedersen, Carsten Helleberg, Emil Hermansen, Brian Iversen Schnack, Annette Juul Vangsted
Published 2021-04-01

Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.

by Rasmus Sørrig, Tobias W Klausen, Morten Salomo, Annette J Vangsted, Ulf Christian Frølund, Kristian T Andersen, Anja Klostergaard, Carsten Helleberg, Robert S Pedersen, Per T Pedersen, Sissel Helm-Petersen, Elena Manuela Teodorescu, Birgitte Preiss, Niels Abildgaard, Peter Gimsing, Danish Myeloma Study Group
Published 2017-01-01

Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial

by Nicolai Grønne Jørgensen, Nicolai Grønne Jørgensen, Uffe Klausen, Uffe Klausen, Jacob Handlos Grauslund, Carsten Helleberg, Thomas Granum Aagaard, Trung Hieu Do, Shamaila Munir Ahmad, Lars Rønn Olsen, Tobias Wirenfeldt Klausen, Marie Fredslund Breinholt, Morten Hansen, Evelina Martinenaite, Özcan Met, Özcan Met, Inge Marie Svane, Lene Meldgaard Knudsen, Mads Hald Andersen, Mads Hald Andersen
Published 2020-11-01